• Some PC Patients Can Safely Receive Short but Intense Course of Radiation
  • Provenge Better for African-Americans Than Men of Other Ethnicities, Analysis Shows
  • Trial To Test Lynparza-Zytiga Combo Recruiting Men with Metastatic Castration-resistant Prostate Cancer
  • Zejula Cuts Tumor Burden in Significant Proportion of Advanced PC Patients
  • Darolutamide Delays Metastasis in High-risk CRPC Patients, Phase 3 Trial Shows
  • Opdivo-Yervoy Combo Shows Signs of Activity in CRPC Patients with Metastases
  • Xtandi, Zytiga Better for African-Americans Than Whites With Advanced Prostate Cancer, Research Finds
  • Leap’s DKN-01 Enters Testing in Metastatic Castration-resistant Prostate Cancers
  • Physicians’ Education Resource to Host 12th Annual Prostate Cancer Congress
  • PSA Testing Cuts Deaths, Shows Value of Long-Term Screening
  • Prostate Cancer UK Grants $355K to University of Birmingham for Development of New Test
  • Xtandi Delays Disease Progression, Death in Metastatic Hormone-Sensitive PC Patients, Trial Shows